Chris Irvine, Inc. – Trademark Portfolio
Entity Type: 03
Chris Irvine, Inc. holds 58 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 51 filings in this category. The portfolio also extends into Class 25 (Clothing) across 5 Nice Classification classes. Currently, 22 trademarks are registered and 11 are pending. Notable registered marks include JAS, FOZZY, DEMO GOD, THE OCHO, and KUARANTINE. The owner is based in Odessa, FL.
18727 Patterson Road
Odessa, FL 33556
Showing of trademarks Trademarks
Trademark Classifications
Chris Irvine, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Chris Irvine, Inc. have?
Chris Irvine, Inc. has 58 U.S. trademarks filed with the USPTO. Of these, 22 registered, 11 pending, 25 abandoned.
What trademark classes does Chris Irvine, Inc. file in?
Chris Irvine, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 25 (Clothing), Class 33 (Wine & Spirits), Class 9 (Computers & Electronics), Class 39 (Transportation & Storage). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Chris Irvine, Inc.'s most well-known trademarks?
Chris Irvine, Inc.'s registered trademark portfolio includes well-known marks such as JAS, FOZZY, DEMO GOD, THE OCHO, and KUARANTINE. These are among 22 currently registered trademarks in the portfolio.
What is Chris Irvine, Inc.'s trademark registration success rate?
Chris Irvine, Inc. has a 47% trademark registration rate, with 22 out of 47 resolved applications resulting in successful registration. Currently, 11 applications are pending review.